Added value of functional neuroimaging to assess decision-making capacity of older adults with neurocognitive disorders: protocol for a prospective, monocentric, single-arm study (IMAGISION)

Thomas Tannou, Aurelie Godard-Marceau, Sven Joubert, Serge Daneault, Marie-Jeanne Kergoat, Eloi Magnin, Alexandre Comte, Damien Gabriel, Chrystelle Vidal, Lionel Pazart, Regis Aubry, Thomas Tannou, Aurelie Godard-Marceau, Sven Joubert, Serge Daneault, Marie-Jeanne Kergoat, Eloi Magnin, Alexandre Comte, Damien Gabriel, Chrystelle Vidal, Lionel Pazart, Regis Aubry

Abstract

Introduction: Assessment of decision-making capacity (DMC) is essential in daily life as well as for defining a person-centred care plan. Nevertheless, in ageing, especially if signs of dementia appear, it becomes difficult to assess decision-making ability and raises ethical questions. Currently, the assessment of DMC is based on the clinician's evaluation, completed by neuropsychological tests. Functional MRI (fMRI) could bring added value to the diagnosis of DMC in difficult situations.

Methods and analysis: IMAGISION is a prospective, monocentric, single-arm study evaluating fMRI compared with clinical assessment of DMC. The study will begin during Fall 2021 and should be completed by Spring 2023. Participants will be recruited from a memory clinic where they will come for an assessment of their cognitive abilities due to decision-making needs to support ageing in place. They will be older people over 70 years of age, living at home, presenting with a diagnosis of mild dementia, and no exclusion criteria of MRI. They will be clinically assessed by a geriatrician on their DMC, based on the neuropsychological tests usually performed. Participants will then perform a behavioural task in fMRI (Balloon Analogue Risk Task) to analyse the activation areas. Additional semistructured interviews will be conducted to explore real life implications. The main analysis will study concordance/discordance between the clinical classification and the activation of fMRI regions of interest. Reclassification as 'capable', based on fMRI, of patients for whom clinical diagnosis is 'questionable' will be considered as a diagnostic gain.

Ethics and dissemination: IMAGISION has been authorised by a research ethics board (Comité de Protection des Personnes, Bordeaux, II) in France, in accordance with French legislation on interventional biomedical research, under the reference IDRCB number 2019-A00863-54, since 30 September 2020. Participants will sign an informed consent form. The results of the study will be presented in international peer-reviewed scientific journals, international scientific conferences and public lectures.

Trial registration number: NCT03931148.

Keywords: dementia; magnetic resonance imaging; medical ethics.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Flow chart. BART, Balloon Analogue Risk Task; EEG-HR, high-resolution electroencephalography; fMRI, functional MRI; IA, Inventaire Apathie; JAT, Jugement Assessment Tool; SEA, Social cognition and EmotionaL Assesment; TM, Trail Making Test.

References

    1. Aubry R. Avis n°128. Enjeux éthiques du vieillissement Quel sens la concentration des personnes âgées entre elles, dans des établissements dits d’hébergement ? Quels leviers pour une société inclusive pour les personnes âgées ? Comité Consultatif National d’Ethique, 2018.
    1. Gzil F. La maladie d’Alzheimer: problèmes philosophiques. Presses universitaires de France, 2009.
    1. Fondation Méderic Alzheimer . Enquête nationale sur les dispositifs de prise en charge et d’accompagnement de la maladie d’Alzheimer, 2018.
    1. Ekdahl AW, Alwin J, Eckerblad J, et al. . Long-Term evaluation of the ambulatory geriatric assessment: a frailty intervention trial (AGe-FIT): clinical outcomes and total costs after 36 months. J Am Med Dir Assoc 2016;17:263–8. 10.1016/j.jamda.2015.12.008
    1. Pilotto A, Cella A, Pilotto A, et al. . Three decades of comprehensive geriatric assessment: evidence coming from different healthcare settings and specific clinical conditions. J Am Med Dir Assoc 2017;18:192.e1–192.e11. 10.1016/j.jamda.2016.11.004
    1. Zielinski A, choix Llibre. De l’autonomie rêvée l’attention aux capacités. Gérontologie Société 2009;131:11–24.
    1. Falk E, Hoffman N. The role of capacity assessments in elder abuse investigations and guardianships. Clin Geriatr Med 2014;30:851–68. 10.1016/j.cger.2014.08.009
    1. Fellows LK. The cognitive neuroscience of human decision making: a review and conceptual framework. Behav Cogn Neurosci Rev 2004;3:159–72. 10.1177/1534582304273251
    1. Kalis A, Mojzisch A, Schweizer TS, et al. . Weakness of will, akrasia, and the neuropsychiatry of decision making: an interdisciplinary perspective. Cogn Affect Behav Neurosci 2008;8:402–17. 10.3758/CABN.8.4.402
    1. Giroux D, Tétreault S, Langlois L. Évaluation de l’aptitude d’une personne âgée atteinte de déficits cognitifs à gérer sa personne et ses biens : Identification des outils disponibles. Can J Aging 2013;32:375–91. 10.1017/S0714980813000482
    1. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98. 10.1016/0022-3956(75)90026-6
    1. Smith T, Gildeh N, Holmes C. The Montreal cognitive assessment: validity and utility in a memory clinic setting. Can J Psychiatry 2007;52:329–32. 10.1177/070674370705200508
    1. Larouche E, Tremblay M-P, Potvin O, et al. . Normative data for the Montreal cognitive assessment in middle-aged and elderly Quebec-French people. Arch Clin Neuropsychol 2016;31:819–26. 10.1093/arclin/acw076
    1. Katz S, Ford AB, Moskowitz RW, et al. . Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963;185:914–9. 10.1001/jama.1963.03060120024016
    1. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179–86. 10.1093/geront/9.3_Part_1.179
    1. Ellis G, Gardner M, Tsiachristas A, et al. . Comprehensive geriatric assessment for older adults admitted to hospital. Cochrane Database Syst Rev 2017;9:CD006211. 10.1002/14651858.CD006211.pub3
    1. Brocker P, Clairet S, Benoit M, et al. . Inventaire Apathie: Evaluation de l’apathie chez des sujets presentant une maladie d’Alzheimer ou un trouble cognitif leger. Rev Gériatrie 2003;28:473–80.
    1. Bertoux M, Delavest M, de Souza LC, et al. . Social cognition and emotional assessment differentiates frontotemporal dementia from depression. J Neurol Neurosurg Psychiatry 2012;83:411–6. 10.1136/jnnp-2011-301849
    1. Bertoux M, Volle E, de Souza LC, et al. . Neural correlates of the mini-SEA (social cognition and emotional assessment) in behavioral variant frontotemporal dementia. Brain Imaging Behav 2014;8:1–6. 10.1007/s11682-013-9261-0
    1. Bertoux M, Volle E, Funkiewiez A, et al. . Social cognition and emotional assessment (sea) is a marker of medial and orbital frontal functions: a voxel-based morphometry study in behavioral variant of frontotemporal degeneration. J Int Neuropsychol Soc 2012;18:972–85. 10.1017/S1355617712001300
    1. Bayard S, Erkes J, Moroni C, et al. . Victoria Stroop test: normative data in a sample group of older people and the study of their clinical applications in the assessment of inhibition in Alzheimer's disease. Arch Clin Neuropsychol 2011;26:653–61. 10.1093/arclin/acr053
    1. Tombaugh TN. Trail making test a and B: normative data stratified by age and education. Arch Clin Neuropsychol 2004;19:203–14. 10.1016/S0887-6177(03)00039-8
    1. de Craen AJM, Heeren TJ, Gussekloo J. Accuracy of the 15-item geriatric depression scale (GDS-15) in a community sample of the oldest old. Int J Geriatr Psychiatry 2003;18:63–6. 10.1002/gps.773
    1. Escudier F, Léveillé E, Charbonneau S, et al. . Evaluating decision-making: validation and regression-based normative data of the judgment assessment tool. Arch Clin Neuropsychol 2016;31:acw019–38. 10.1093/arclin/acw019
    1. Gaubert F, Chainay H. Decision-Making competence in patients with Alzheimer's disease: a review of the literature. Neuropsychol Rev 2021;31:267–87. 10.1007/s11065-020-09472-2
    1. Bechara A, Damasio H, Damasio AR, et al. . Different contributions of the human amygdala and ventromedial prefrontal cortex to decision-making. J Neurosci 1999;19:5473–81. 10.1523/JNEUROSCI.19-13-05473.1999
    1. Bechara A, Damasio AR, Damasio H, et al. . Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994;50:7–15. 10.1016/0010-0277(94)90018-3
    1. Lejuez CW, Read JP, Kahler CW, et al. . Evaluation of a behavioral measure of risk taking: the balloon analogue risk task (BART). J Exp Psychol Appl 2002;8:75–84. 10.1037/1076-898X.8.2.75
    1. Rao H, Korczykowski M, Pluta J, et al. . Neural correlates of voluntary and involuntary risk taking in the human brain: an fMRI study of the balloon analog risk task (BART). Neuroimage 2008;42:902–10. 10.1016/j.neuroimage.2008.05.046
    1. Halfmann K, Hedgcock W, Bechara A, et al. . Functional neuroimaging of the Iowa gambling task in older adults. Neuropsychology 2014;28:870–80. 10.1037/neu0000120
    1. Tannou T, Magnin E, Comte A, et al. . Neural activation in risky decision-making tasks in healthy older adults: a meta-analysis of fMRI data. Brain Sci 2021;11:1043. 10.3390/brainsci11081043
    1. Bossuyt PM, Reitsma JB, Bruns DE, et al. . Stard 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 2015;351:h5527. 10.1136/bmj.h5527
    1. Jeste DV, Palmer BW, Appelbaum PS, et al. . A new brief instrument for assessing decisional capacity for clinical research. Arch Gen Psychiatry 2007;64:966–74. 10.1001/archpsyc.64.8.966
    1. Duron E, Boulay M, Vidal JS, et al. . Capacity to consent to biomedical research's evaluation among older cognitively impaired patients. A study to validate the University of California brief assessment of capacity to consent questionnaire in French among older cognitively impaired patients. J Nutr Health Aging 2013;17:385–9. 10.1007/s12603-013-0036-5
    1. Dubois B, Slachevsky A, Litvan I, et al. . The Fab: a frontal assessment battery at bedside. Neurology 2000;55:1621–6. 10.1212/WNL.55.11.1621
    1. Migliorelli R, Tesón A, Sabe L, et al. . Anosognosia in Alzheimer's disease: a study of associated factors. J Neuropsychiatry Clin Neurosci 1995;7:338–44. 10.1176/jnp.7.3.338
    1. Walker D, Myrick F. Grounded theory: an exploration of process and procedure. Qual Health Res 2006;16:547–59. 10.1177/1049732305285972
    1. Glaser B, Strauss A. Grounded theory: the discovery of grounded theory. Sociol J Br Sociol Assoc 1967;12:27–49.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever